Paper8551575
A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes.
Devergne O and 6 others. J Virol, 1996. Cited by 290 papers, by iCite.
Cite this record
ConductScience Library. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. Papers, record 8551575. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8551575
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics27
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| B-Lymphocytes | Major topic |
| Glycoproteins | Major topic |
| Herpesvirus 4, Human | Major topic |
| Interleukin-12 | Major topic |
| Receptors, Cytokine | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Base Sequence | |
| Calcium-Binding Proteins | |
| Calnexin | |
| Cell Line | |
| Cell Membrane | |
| Chromosome Mapping | |
| Chromosomes, Human, Pair 19 | |
| Cloning, Molecular | |
| Cytoplasm | |
| DNA Primers | |
| DNA, Complementary | |
| HeLa Cells | |
| Humans | |
| Interleukins | |
| Minor Histocompatibility Antigens | |
| Molecular Sequence Data | |
| Receptor, Ciliary Neurotrophic Factor | |
| Receptors, Nerve Growth Factor | |
| Viral Matrix Proteins | |
| Virus Latency |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA07446 | NCI NIH HHS | United States | PubMed | PubMed | |
| CA62375 | NCI NIH HHS | United States | R29CA062375 | PubMed and NIH | NIH RePORTER |
References63
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7527811 | Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. | J Immunol | 1995 | https://conductscience.org/library/papers/7527811 | PubMed |
| 2 | 1648265 | The receptor for ciliary neurotrophic factor. | Science | 1991 | https://conductscience.org/library/papers/1648265 | PubMed |
| 3 | 7859281 | The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. | Cell | 1995 | https://conductscience.org/library/papers/7859281 | PubMed |
| 4 | 7816815 | Increased cell surface expression and enhanced folding in the endoplasmic reticulum of a mutant erythropoietin receptor. | Proc Natl Acad Sci U S A | 1995 | https://conductscience.org/library/papers/7816815 | PubMed |
| 5 | 5242134 | Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. | Proc Natl Acad Sci U S A | 1968 | https://conductscience.org/library/papers/5242134 | PubMed |
| 6 | 4332899 | The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV. | Int J Cancer | 1971 | https://conductscience.org/library/papers/4332899 | PubMed |
| 7 | 6305160 | Phenotypic and cytogenetic characteristics of human B-lymphoid cell lines and their relevance for the etiology of Burkitt's lymphoma. | Adv Cancer Res | 1982 | https://conductscience.org/library/papers/6305160 | PubMed |
| 8 | 6309371 | Self-stimulating growth factor production by B-cell lines derived from Burkitt's lymphomas and other lines transformed in vitro by Epstein-Barr virus. | Cancer Res | 1983 | https://conductscience.org/library/papers/6309371 | PubMed |
| 9 | 3871451 | Studies of in vitro activation and differentiation of human B lymphocytes. I. Phenotypic and functional characterization of the B cell population responding to anti-Ig antibody. | J Immunol | 1985 | https://conductscience.org/library/papers/3871451 | PubMed |
| 10 | 2984280 | BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus. | J Immunol | 1985 | https://conductscience.org/library/papers/2984280 | PubMed |
| 11 | 2989413 | Early events in Epstein-Barr virus infection provide a model for B cell activation. | J Exp Med | 1985 | https://conductscience.org/library/papers/2989413 | PubMed |
| 12 | 3934070 | The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt's lymphoma. | IARC Sci Publ | 1985 | https://conductscience.org/library/papers/3934070 | PubMed |
| 13 | 3005176 | Epstein-Barr virus status and tumour cell phenotype in sporadic Burkitt's lymphoma. | Int J Cancer | 1986 | https://conductscience.org/library/papers/3005176 | PubMed |
| 14 | 3090143 | Identification of an early activation antigen (Bac-1) on human B cells. | J Immunol | 1986 | https://conductscience.org/library/papers/3090143 | PubMed |
| 15 | 1313713 | Interleukin-5 is an autocrine growth factor for Epstein-Barr virus-transformed B lymphocytes. | Blood | 1992 | https://conductscience.org/library/papers/1313713 | PubMed |
| 16 | 1584811 | Endoplasmic reticulum resident protein of 90 kilodaltons associates with the T- and B-cell antigen receptors and major histocompatibility complex antigens during their assembly. | Proc Natl Acad Sci U S A | 1992 | https://conductscience.org/library/papers/1584811 | PubMed |
| 17 | 1326756 | The major histocompatibility complex class I antigen-binding protein p88 is the product of the calnexin gene. | Proc Natl Acad Sci U S A | 1992 | https://conductscience.org/library/papers/1326756 | PubMed |
| 18 | 1357073 | Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. | J Exp Med | 1992 | https://conductscience.org/library/papers/1357073 | PubMed |
| 19 | 8381152 | Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10. | J Exp Med | 1993 | https://conductscience.org/library/papers/8381152 | PubMed |
| 20 | 8382256 | Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines. | J Exp Med | 1993 | https://conductscience.org/library/papers/8382256 | PubMed |
Cited by146
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 290 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42063709 | Metastatic adenocarcinomas of left colon and rectum: differences in clinical outcome and gene expression. | Front Oncol | 2026 | https://conductscience.org/library/papers/42063709 | PubMed |
| 40663802 | The biology of interleukin-6 family cytokines is regulated by glycosylation. | Biochem J | 2025 | https://conductscience.org/library/papers/40663802 | PubMed |
| 40622445 | Recent Insights Into Targeting Interleukin-27 in Coronary Artery Disease. | J Cardiovasc Transl Res | 2025 | https://conductscience.org/library/papers/40622445 | PubMed |
| 40114923 | IL-6/IL-12 superfamily of cytokines and regulatory lymphocytes play critical roles in the etiology and suppression of CNS autoimmune diseases. | Front Immunol | 2025 | https://conductscience.org/library/papers/40114923 | PubMed |
| 40093899 | Interleukin 35-producing B cells prolong the survival of GVHD mice by secreting exosomes with membrane-bound IL-35 and upregulating PD-1/LAG-3 checkpoint proteins. | Theranostics | 2025 | https://conductscience.org/library/papers/40093899 | PubMed |
| 40048708 | IL-27 producers in a neonatal BCG vaccination model are a heterogenous population of myeloid cells that are diverse in phenotype and function. | Immunohorizons | 2025 | https://conductscience.org/library/papers/40048708 | PubMed |
| 39906735 | Revisiting the role of IL-27 in obesity-related metabolic diseases: safeguard or perturbation? | Front Immunol | 2024 | https://conductscience.org/library/papers/39906735 | PubMed |
| 39810405 | The influence of interleukin-27 on metabolic fitness in a murine neonatal model of bacterial sepsis. | Am J Physiol Endocrinol Metab | 2025 | https://conductscience.org/library/papers/39810405 | PubMed |
| 39797931 | Harnessing IL-27: challenges and potential in cancer immunotherapy. | Clin Exp Med | 2025 | https://conductscience.org/library/papers/39797931 | PubMed |
| 39291183 | Low EBI3 Expression Promotes the Malignant Degree of Gastric Cancer. | Dis Markers | 2022 | https://conductscience.org/library/papers/39291183 | PubMed |
| 39063193 | Role of IL-27 in COVID-19: A Thin Line between Protection and Disease Promotion. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39063193 | PubMed |
| 38966644 | IL-27 expression regulation and its effects on adaptive immunity against viruses. | Front Immunol | 2024 | https://conductscience.org/library/papers/38966644 | PubMed |
| 38509369 | Role of IL-27 in Epstein-Barr virus infection revealed by IL-27RA deficiency. | Nature | 2024 | https://conductscience.org/library/papers/38509369 | PubMed |
| 37878703 | Human interleukin-12α and EBI3 are cytokines with anti-inflammatory functions. | Sci Adv | 2023 | https://conductscience.org/library/papers/37878703 | PubMed |
| 37289499 | Human IL-35 Inhibits the Bioactivity of IL-12 and Its Interaction with IL-12Rβ2. | Immunohorizons | 2023 | https://conductscience.org/library/papers/37289499 | PubMed |
| 37108513 | Potential of Interleukin (IL)-12 Group as Antivirals: Severe Viral Disease Prevention and Management. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37108513 | PubMed |
| 36891292 | Interleukin-27-dependent transcriptome signatures during neonatal sepsis. | Front Immunol | 2023 | https://conductscience.org/library/papers/36891292 | PubMed |
| 36873098 | Evolutionarily conserved IL-27β enhances Th1 cells potential by triggering the JAK1/STAT1/T-bet axis in Nile tilapia. | Fish Shellfish Immunol Rep | 2023 | https://conductscience.org/library/papers/36873098 | PubMed |
| 36548354 | Epstein-Barr virus-induced gene 3 commits human mesenchymal stem cells to differentiate into chondrocytes via endoplasmic reticulum stress sensor. | PLoS One | 2022 | https://conductscience.org/library/papers/36548354 | PubMed |
| 36050707 | IL-27 shapes the immune properties of human astrocytes and their impact on encountered human T lymphocytes. | J Neuroinflammation | 2022 | https://conductscience.org/library/papers/36050707 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EBI3 | 10148 | Swiss-Prot's references | https://conductscience.org/library/genes/10148 | NCBI Gene |
| SQSTM1 | 8878 | Swiss-Prot's references | https://conductscience.org/library/genes/8878 | NCBI Gene |
| CANX | 821 | PubTator's text mining | https://conductscience.org/library/genes/821 | NCBI Gene |
| CNTFR | 1271 | PubTator's text mining | https://conductscience.org/library/genes/1271 | NCBI Gene |
| EPOR | 2057 | PubTator's text mining | https://conductscience.org/library/genes/2057 | NCBI Gene |
| IL12B | 3593 | PubTator's text mining | https://conductscience.org/library/genes/3593 | NCBI Gene |
| TYK2 | 7297 | PubTator's text mining | https://conductscience.org/library/genes/7297 | NCBI Gene |
Data2
The data bank entries PubMed's record names. Trial numbers are under Trials.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8551575
GET https://conductscience.org/api/papers/v1/8551575/references?page=2